Live from the NIH registry
Studies recruiting near New Bedford right now
Top 25 of 519 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Velocity Clinical Research, Providence (East Greenwich) — East Greenwich, Rhode Island (26.5 mi)
· Sponsor: AbbVie
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
Acute Ischemic Stroke
N/A
Interventional 408 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Amrou Sarraj
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Providence, Rhode Island (26.5 mi)
· Sponsor: Daiichi Sankyo
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Alcohol Use Disorder (AUD)
Phase 2
Interventional 184 participants sought
Brown University — Providence, Rhode Island (26.5 mi)
· Sponsor: Brown University
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Hasbro Children's Hospital - PIN — Providence, Rhode Island (26.5 mi)
· Sponsor: Takeda
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: NRG Oncology
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Lifespan Cancer Institute — Providence, Rhode Island (26.5 mi)
· Sponsor: Regeneron Pharmaceuticals
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Providence, Rhode Island (26.5 mi)
· Sponsor: AstraZeneca
Community-Partnered Doula Support for Neonatal Intensive Care Unit Families
Infant Admitted to Neonatal Intensive Care Unit (NICU), Doula Support
N/A
Interventional 60 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Women and Infants Hospital of Rhode Island
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early Onset Alzheimer Disease, Alzheimer Disease
N/A
Observational 850 participants sought
Butler Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Indiana University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Providence Veterans Administration Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
2951, The Miriam Hospital (TMH) CRS — Providence, Rhode Island (26.5 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Fairhaven, Massachusetts (3.0 mi)
· Sponsor: AstraZeneca
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Women & Infants Hospital /ID# 274716 — Providence, Rhode Island (26.5 mi)
· Sponsor: AbbVie
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Relapsed/Refractory Primary Central Nervous System Lymphoma
Phase 3
Interventional 132 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
Alzheimer Disease, Early Onset, Mild Cognitive Impairment
Phase 1
Interventional 35 participants sought
Memory and Aging Program, Butler Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Butler Hospital
Cannabis' Impact on Alcohol Consumption
Alcohol Drinking, Cannabis Use
Phase 2
Interventional 350 participants sought
Brown University — Providence, Rhode Island (26.5 mi)
· Sponsor: Brown University
RCT of Pain Perception With Fast and Slow Tenaculum Application
Pain, Acute, Pain, Procedural
N/A
Interventional 150 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: Women and Infants Hospital of Rhode Island
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Women & Infants Hospital of Rhode Island — Providence, Rhode Island (26.5 mi)
· Sponsor: Context Therapeutics Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Women and Infants Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: NRG Oncology
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Rectal Cancer, Rectal Tumor
N/A
Interventional 250 participants sought
Lifespan & Brown Surgical Associates — Providence, Rhode Island (26.5 mi)
· Sponsor: Colospan Ltd.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Rhode Island Hospital — Providence, Rhode Island (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
Letrozole in Uterine Leiomyosarcoma
Uterine Leiomyosarcoma
Phase 2
Interventional 40 participants sought
Woman and Infants Hospital of Rhode Island — Providence, Rhode Island (26.5 mi)
· Sponsor: GOG Foundation